Reuters/International Herald Tribune and the Wall Street Journal (subscription required for WSJ access) are reporting that GlaxoSmithKline intends to cut 850 research and development (R&D) jobs in the United States and the United Kingdom--6% of Glaxo's R&D staff. These job cuts are on top of 350 announced earlier this year, meaning that Glaxo is eliminating 8+% of their R&D workforce.
September 30, 2008
Big R&D Job Cuts at GlaxoSmithKline
TrackBacks
TrackBack URL for this entry:
http://blogs.sciencemag.org/cgi-bin/mt/mt-tb.cgi/1971
Listed below are links to weblogs that reference: Big R&D Job Cuts at GlaxoSmithKline.
R&D is an important sector for development. However, job slash is happening everywhere due to recession.more are yet to come i guess..